Investor & partners

ImmunoPharma we are passionate about science: yours and ours. Through partnerships we can build a better future together with medicines that make a real difference to patients

OUR AREAS
OF FOCUS

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following: Cancer Treatment, Inflammatory Bowel Disease, Health Supplement.

  • chart-line

    Cancer Treatment

    Cancer is a generic term for a large group of diseases that can affect any part of the body

  • chart-line

    Inflammatory Bowel Disease

    Inflammatory are chronic, idiopathic inflammatory conditions, which probably involve an immune reaction of the body

  • chart-line

    Health Supplement

    There is considerable interest in AndoSan™ from people with various ailments and as a general promoter of immune health.

MARKET POTENTIAL

The primary goal is to gain acceptance for AndoSan™ as part of standardized treatment regimens within the public health service.

Other potentially interesting areas of application includes multi resistant bacterial infections and various allergies. In addition to the medical market, improved production and reduced production costs will open up a considerable potential for a health supporting supplement in the mass-market.

FUTURE
PLAN

  • chart-line
    icon--future-increase

    Increase marketing & sales

  • chart-line
    icon--future-under

    Under evaluation

  • chart-line
    icon--future-decrease

    Decrease production costs, planning to launch 2017

For investors and partners

See more